United States · FDA National Drug Code directory

Dasatinib

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0480-3523_97769ebd-872d-4851-bf3f-51630e995dd6
Product NDC
0480-3523
Form
TABLET, FILM COATED
Composition / generic term
Dasatinib
Labeler
Teva Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20250918
Source listing expiry
20271231

Source-listed ingredients

  • DASATINIB — 80 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (0480-3523-56) · 0480-3523-56

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →